Merida Capital

Steep Hill is a science and technology company focused on cannabis and hemp markets, offering testing, analytics, and research services across medical and recreational cannabis, and related hemp products. The company operates laboratories to perform potency testing, safety screening, cultivation science, and genetic analysis, and provides scientific consulting to legislators and regulators worldwide. Founded in 2008 and headquartered in Berkeley, California, Steep Hill opened the first commercial cannabis lab in the United States and has since expanded its footprint internationally. In addition to lab services, it offers advisory support to regulatory bodies and conducts research and development in genetics, licensing, and remote testing to advance public safety standards. Through its subsidiaries, Steep Hill holds industrial hemp licenses for supplying cannabidiol and other cannabinoid-based products. This reflects a diversified focus on cannabis science, testing, and regulatory consultancy.

Steep Hill is a science and technology company focused on cannabis and hemp markets, offering testing, analytics, and research services across medical and recreational cannabis, and related hemp products. The company operates laboratories to perform potency testing, safety screening, cultivation science, and genetic analysis, and provides scientific consulting to legislators and regulators worldwide. Founded in 2008 and headquartered in Berkeley, California, Steep Hill opened the first commercial cannabis lab in the United States and has since expanded its footprint internationally. In addition to lab services, it offers advisory support to regulatory bodies and conducts research and development in genetics, licensing, and remote testing to advance public safety standards. Through its subsidiaries, Steep Hill holds industrial hemp licenses for supplying cannabidiol and other cannabinoid-based products. This reflects a diversified focus on cannabis science, testing, and regulatory consultancy.